Article

Strong bones, osteoporosis prevention with an active childhood

Physical activity performed at an early age results in sustained improvement in bone health evidenced by higher bone mineral content (BMC).

Physical activity performed at an early age results in sustained improvement in bone health evidenced by higher bone mineral content (BMC). Early childhood may be an important developmental period for promoting physical activity to optimize peak bone mass during young adulthood and prevent osteoporosis during later years.

Janz and colleagues studied 333 participants in the Iowa Bone Development Study. They looked at how physical activity at age 5 years affects bone density at 8 and 11 years, after correcting for height, weight, age, maturity, and activity.

The children who were most active at 5 years had the highest BMC at 8 and 11 years. The most active children had 4% to 14% higher BMC levels than the least active ones. For boys, the BMC increase at the whole body, spine, and hip was 8%, 14%, and 11%, respectively, by 8 years and 5%, 7%, and 7%, respectively, by 11 years. For girls, the BMC increases were 6%, 8%, and 8% by 8 years and 4%, 6%, and 5% by 11 years.

The authors noted that less active young children may miss the opportunity to obtain the highest peak BMC later in life, when they are likely to be less active.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.